Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polygala senega root, also known as **senega root** or **Seneca snakeroot**, is a botanical medicine derived from the dried roots of *Polygala senega*. It has a long history of use in North American traditional medicine and was officially recognized in the U.S. pharmacopeia as early as 1921. The root's primary therapeutic application is as an expectorant for respiratory conditions, including **chronic bronchitis**, **asthma**, and **emphysema**. Its activity is attributed to a high concentration of triterpenoid saponins (such as senegins and senegasaponins), which act by irritating the gastric mucosa, thereby triggering a reflex increase in bronchial secretions and reducing mucus viscosity. While it is available in various herbal extracts and homeopathic preparations (e.g., by **Boiron**), it is not currently being developed as a proprietary synthetic drug by a single pharmaceutical company.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polygala senega root.